Innovations in Industrial Technologies | Innoget
Find novel Industrial Technologies innovations, as well as inventions in Industrial Equipment, Chemicals, Industrial Processes and more, from world-class scientist, inventors and organizations.
Find novel Industrial Technologies innovations, as well as inventions in Industrial Equipment, Chemicals, Industrial Processes and more, from world-class scientist, inventors and organizations.
Arkadiusz Rudawski, PhDCracow University of TechnologyArkadiusz Rudawski, PhD posted this:
Technology Broker at Cracow University of Technology
Arkadiusz Rudawski, PhDCracow University of TechnologyArkadiusz Rudawski, PhD posted this:
Technology Broker at Cracow University of Technology
Arkadiusz Rudawski, PhDCracow University of TechnologyArkadiusz Rudawski, PhD posted this:
Technology Broker at Cracow University of Technology
Arkadiusz Rudawski, PhDCracow University of TechnologyArkadiusz Rudawski, PhD posted this:
Technology Broker at Cracow University of Technology
Arkadiusz Rudawski, PhDCracow University of TechnologyArkadiusz Rudawski, PhD posted this:
Technology Broker at Cracow University of Technology
Covid-19 Innovation Challenges by InnogetCovid-19 Innovation Challenges by InnogetCovid-19 Innovation Challenges by Innoget posted this:
Expertise in molecular biology either experimentally or computationallyThe Institut de Biotecnologia i de Biomedicina (IBB) was created in 1970 as a research institute of the Universitat Autònoma de Barcelona (UAB) to promote fundamental biological research. In the year 2000, the focus of research evolved towards the Biotechnology and Biomedicine fields, with the aim of advancing scientific findings into translational results. At present, the Institute hosts 18 research groups organised into 3 programmes and working in 7 areas of expertise: • Bioinformatics • Cellular Biology • Structural Biology • Genomics • Immunology • Microbiology • Proteomics. This multidisciplinary character, one of the most relevant characteristics of the IBB, allows for a broad approach to biological problems, both basic and applied. The IBB is also highly engaged in academic training at the undergraduate and postgraduate levels.
TEC Edmonton posted this:
Inhibitors of Viral Infectivity: Amphipathic Nucleoside Derivatives as Fusion InhibitorsA series of small pharmacological molecules have been discovered to be potent and non-cytotoxic inhibitors of viral fusion. The inhibitors act on the non-virally encoded lipids in the virion envelope. These molecules are rigid amphipathic compounds of inverted cone shape which locate to the outer leaflets of virion envelopes, creating a physical barrier to viral envelope and cell membrane fusion. These amphipathic nucleoside derivatives can serve as potential antiviral or therapeutic agents against herpes, HIV, influenza, hepatitis B & C, poxvirus and other DNA or RNA enveloped viruses. They can potentially be used as prophylactic ingredients in creams, lotions, gels and as antiviral disinfectants.
Covid-19 Innovation Challenges by InnogetCovid-19 Innovation Challenges by InnogetCovid-19 Innovation Challenges by Innoget posted this:
Inhibitors of Viral Infectivity: Amphipathic Nucleoside Derivatives as Fusion InhibitorsA series of small pharmacological molecules have been discovered to be potent and non-cytotoxic inhibitors of viral fusion. The inhibitors act on the non-virally encoded lipids in the virion envelope. These molecules are rigid amphipathic compounds of inverted cone shape which locate to the outer leaflets of virion envelopes, creating a physical barrier to viral envelope and cell membrane fusion. These amphipathic nucleoside derivatives can serve as potential antiviral or therapeutic agents against herpes, HIV, influenza, hepatitis B & C, poxvirus and other DNA or RNA enveloped viruses. They can potentially be used as prophylactic ingredients in creams, lotions, gels and as antiviral disinfectants.
Pascal Mayer posted this:
CEO at Alphanosos
Arkadiusz Rudawski, PhDCracow University of TechnologyArkadiusz Rudawski, PhD posted this:
Technology Broker at Cracow University of Technology
Alex Michine posted this:
CEO at MetGen
ADVANCED PASSIVE TECHNOLOGYADVANCED PASSIVE TECHNOLOGYADVANCED PASSIVE TECHNOLOGY posted this:
Independent Researcher&Inventor
Universitat Politècnica de Catalunya - UPCUniversitat Politècnica de Catalunya - UPCUniversitat Politècnica de Catalunya - UPC posted this:
Single step slicing ultra thin crystalline Silicon layers from Si wafersA new technology to obtain ultra thin crystalline Silicon layers has been developed and patented. This innovative method allows to manufacture controllable thin film thickness using only a single step. Partners to further develop the system and/or to establish commercial agreements along with technical cooperation are sought.
Unitat de Valorització de la URVFundació URVUnitat de Valorització de la URV posted this:
Licensing Manager at Fundació URV
Universitat Politècnica de Catalunya - UPCUniversitat Politècnica de Catalunya - UPCUniversitat Politècnica de Catalunya - UPC posted this:
Solar desalination plant for sea water, waste water or brineA new system of seawater desalination has been developed, consisting of a solar heat collector made of a transparent film surface in a pyramidshaped tent and another dark one (to retain the maximum amount of heat) material inner truncated pyramid parallel to the former, generating a layer of heated air. Heat accumulates at the vertex, where high temperatures are achieved. This allows the evaporation of seawater injected by micronebulizers, resulting into moisture-laden air being pulled by a central axial tube leading to a 'cold spot' located underground. Here a network of galleries, filled with the stored water, provides cold temperature to dissipate heat and to condense the steam into pure water. Partners to further develop the technology and/or to establish commercial agreements along with technical cooperation are sought.
